Commodity
Chapter
30 PHARMACEUTICAL PRODUCTSSub Chapter
3002 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micrSub Heading
300210 Abagovomab (INN), Abatacept (INN), Abciximab, Adalimumab (INN), Adecatumumab (INN), Afelimomab, Aflibercept (INN), Afutuzumab, Alacizumab pegol, Alefacept (INN), Alemtuzumab (INN), Altumomab, Anatumomab mafenatox (INN), Ancestim (INN), Anrukinzumab, AntisCode
30021000 Abagovomab (INN), Abatacept (INN), Abciximab, Adalimumab (INN), Adecatumumab (INN), Afelimomab, Aflibercept (INN), Afutuzumab, Alacizumab pegol, Alefacept (INN), Alemtuzumab (INN), Altumomab, Anatumomab mafenatox (INN), Ancestim (INN), Anrukinzumab, Antis
Tariffs
Displaying 1-6 of 6 result(s).
| Country Group | Group Description | Activity | Tariff Rate | Unit | Valid From | Valid To |
|---|---|---|---|---|---|---|
| ID-SAARC | Import Duty - SAARC Countries | Import | Free | KGM | 01-01-2016 | 31-12-9999 |
| ID-OTHER | Import Duty - Other Countries | Import | Free | KGM | 01-01-2016 | 31-12-9999 |
| TOT-INDIA | Total Applicable Duty Rate - India | Import | dfkmL | KGM | 01-01-2016 | 31-12-9999 |
| TOT-OSAARC | Total Applicable Duty Rate - Other SAARC Countries | Import | dfkmL | KGM | 01-01-2016 | 31-12-9999 |
| TOT-TIBET | Total Applicable Duty Rate - Tibet Autonomous Region | Import | dfkmL | KGM | 01-01-2016 | 31-12-9999 |
| TOT-OTHER | Total Applicable Duty Rate - Others | Import | dfkmL | KGM | 01-01-2016 | 31-12-9999 |